Israelis Construct First-Ever ‘Blue-And-White’ CAR T Cancer Treatment
A team of Israeli scientists and doctors have developed the country’s first blue-and-white CAR T immunotherapy for the treatment of multiple myeloma, potentially giving thousands of sick patients access to this life-saving treatment.
Multiple myeloma is a still incurable cancer within the spongy bone marrow.
A Phase I clinical trial kicked off during the COVID-19 pandemic. So far, seven patients have received the treatment, and it is proving safe and effective. (JPost / VFI News)
For I know the plans I have for you, declares the Lord, plans for welfare and not for evil, to give you a future and a hope. - Jeremiah 29:11
The suggestions, opinions, and scripture references made by VFI News writers and editors are based on the best information received.
Want to see more from VFI? Follow us on Facebook! Our official Facebook name is Vision for Israel. Follow us there and please hit “like” if you like us.